Free Trial
NASDAQ:KBLM

KBL Merger Corp. IV (KBLM) Stock Price, News & Analysis

→ The Hard Truth About Investing For Retirement (From Insiders Exposed) (Ad)
Free KBLM Stock Alerts
Notice: This company has been marked as potentially delisted and may not be actively trading.
Today's Range
$1.76
▼
$2.00
50-Day Range
$2.15
▼
$11.04
52-Week Range
$4.60
▼
$11.50
Volume
31,756 shs
Average Volume
17,547 shs
Market Capitalization
$9.67 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Stock AnalysisCompetitorsSocial Media

About KBL Merger Corp. IV

KBL Merger Corp. IV is a private equity firm specializing in acquisition, buyout, PIPES and secondaries investments. The firm seeks to invest in healthcare or the healthcare-related wellness industry. In healthcare services the firm seeks to invest in outpatient care, physician practices, behavioral health and payor services. In pharma services the firm seeks to invest in outsourced services, contract research and generics / OTC. In health IT the firm seeks to invest in EMR / HER, revnue cycle management, telemedicine and care management. In minimal reimbursement risk the firm focuses on retail healthcare, wellness and preventative care. In devices and diagnostics the firm focuses on medical devices, diagnostics, genetic testing and lab tools. The firm typically invests in firms located in the United States. The firm seeks to invest in firms with valuation between $200 million to $700 million and EBITDA between $20 million to $70 million. The firms invest in firms with enterprise value $200 million to $700 million. The firm seeks to take majority stakes. KBL Merger Corp. IV was founded in 2016 and is New York, New York with an additional office in Newark, Delaware.

KBLM Stock News Headlines

October 31, 2023 | markets.businessinsider.com
Blue Ridge Bankshares, Inc. Announces Third Quarter 2023 Results
September 14, 2023 | finance.yahoo.com
AnyTech365, a Worldwide Leader in AI Powered IT Security, to Go Public Through Merger With Zalatoris Acquisition Corp.
April 23, 2024 | DTI (Ad)
Here’s how to start a “Weekend Side Hustle” from your sofa
Here’s how you can start your very own “Weekend Side Hustle” right from the comfort of your sofa! It doesn't matter if you have a multi-million dollar retirement account… Or if you’re just starting out with a few thousand.
October 17, 2022 | theguardian.com
Rupert Murdoch considering merging Fox and News Corp once again
October 5, 2022 | nasdaq.com
With 48% ownership, Graf Acquisition Corp. IV (NYSE:GFOR) has piqued the interest of institutional investors
September 12, 2022 | markets.businessinsider.com
Watermark Lodging Trust Announces Stockholder Approval of Acquisition by Brookfield
See More Headlines
Receive KBLM Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for KBL Merger Corp. IV and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
N/A
Industry
Holding & Other Investment Offices
Sub-Industry
N/A
Current Symbol
NASDAQ:KBLM
CUSIP
N/A
CIK
1690080
Web
www.kblmerger.com
Phone
302-502-2727
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

EPS (Most Recent Fiscal Year)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-90,000.00
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-56.81%
Return on Assets
-12.76%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
0.34
Quick Ratio
0.34

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$1.12 per share
Price / Book
1.61

Miscellaneous

Outstanding Shares
5,372,000
Free Float
N/A
Market Cap
$9.67 million
Optionable
Not Optionable
Beta
0.17
20 Stocks to Sell Now Cover
20 Stocks to Sell Now

MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.

Get This Free Report

Key Executives

  • Dr. Marlene R. Krauss M.D. (Age 74)
    CEO & Director
  • Mr. Joseph A. Williamson (Age 67)
    COO & Director
  • Dr. Jean-Pierre Garnier Ph.D. (Age 73)
    Scientific Advisor
  • Dr. Myron L. Weisfeldt M.D.
    Scientific Advisor
  • Dr. Phyllis I. Gardner (Age 69)
    Scientific Advisor
  • Dr. Roy G. Geronemus (Age 67)
    Scientific Advisor
  • Ms. Ellen R. Marram (Age 73)
    Special Advisor

KBLM Stock Analysis - Frequently Asked Questions

What other stocks do shareholders of KBL Merger Corp. IV own?

Based on aggregate information from My MarketBeat watchlists, some companies that other KBL Merger Corp. IV investors own include AbbVie (ABBV), Algonquin Power & Utilities (AQN), BCE (BCE), Blackrock Resources & Commodities Strategy Trust (BCX), Franklin Resources (BEN), BlackRock Enhanced International Dividend Trust (BGY), Bank of Nova Scotia (BNS), BlackRock Enhanced Global Dividend Trust (BOE), British American Tobacco (BTI) and BlackRock Utilities, Infrastructure & Power Opportunities Trust (BUI).

This page (NASDAQ:KBLM) was last updated on 4/23/2024 by MarketBeat.com Staff

From Our Partners
Healthcare Takes A Big Step Forward With The Help Of AI
The Bull Report
This Apple-like Innovator is Revolutionizing Healthcare
Wall Street Star
top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)
Traders Agency
Don’t Miss Out on the AI Gold Rush That’s Just Getting Started
Banyan Hill Publishing
Did You Get Your Free Bitcoin Yet?
Crypto Swap Profits
[Shocking] Elon Musk’s Plan To End Banks
Crypto 101 Media
Forget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THIS
Paradigm Press
Exposed: 10 CENT Crypto to Explode April 20th?
True Market Insiders